Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
231.64
-4.80 (-2.03%)
May 1, 2026, 10:58 AM EDT - Market open
Humana Stock Forecast
Stock Price Forecast
The 20 analysts that cover Humana stock have a consensus rating of "Hold" and an average price target of $251.15, which forecasts a 8.42% increase in the stock price over the next year. The lowest target is $158 and the highest is $345.
Price Target: $251.15 (+8.42%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Humana stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 4 | 3 | 3 | 3 |
| Hold | 11 | 11 | 12 | 13 | 13 | 13 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 17 | 18 | 18 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $195 → $262 | Hold | Maintains | $195 → $262 | +13.11% | Apr 30, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $189 → $246 | Hold | Maintains | $189 → $246 | +6.20% | Apr 30, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $252 → $269 | Strong Buy | Maintains | $252 → $269 | +16.13% | Apr 30, 2026 |
| Barclays | Barclays | Hold Maintains $176 → $180 | Hold | Maintains | $176 → $180 | -22.29% | Apr 30, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $195 → $250 | Hold | Maintains | $195 → $250 | +7.93% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
163.57B
from 129.66B
Increased by 26.15%
Revenue Next Year
173.49B
from 163.57B
Increased by 6.07%
EPS This Year
9.33
from 9.84
Decreased by -5.14%
EPS Next Year
15.17
from 9.33
Increased by 62.53%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 176.8B | 193.4B | ||||||
| Avg | 163.6B | 173.5B | ||||||
| Low | 156.5B | 160.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 36.4% | 18.2% | ||||||
| Avg | 26.1% | 6.1% | ||||||
| Low | 20.7% | -2.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 14.30 | 20.40 | ||||||
| Avg | 9.33 | 15.17 | ||||||
| Low | 4.90 | 10.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 45.3% | 118.6% | ||||||
| Avg | -5.1% | 62.5% | ||||||
| Low | -50.2% | 14.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.